Please try another search
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops Legio X, a COVID-19 rapid antigen test that validating the Gemina Surface Chemistry on this platform; and LEGIO X, an influenza AB multiplex lateral flow test. It is also developing a pipeline of products for the diagnosis of infectious respiratory diseases. The company was incorporated in 2017 and is headquartered in Burnaby, Canada.
Name | Age | Since | Title |
---|---|---|---|
John Davies | - | 2022 | Independent Chairman |
Brian Firth | - | 2022 | CEO & Director |
Bola Grace | - | 2023 | Independent Director |
Hugh McNaught | - | 2020 | VP of Marketing & Member of Advisory Board |
Robert Crandall Greene | - | - | CTO & Director |
Martha Najib | - | 2023 | Independent Director |
Martin Cronin | 57 | - | Independent Director |
Michael Edward Shannon | 76 | 2022 | Chair of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review